Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#4359 Treatment response and survival in 163 metastatic colorectal neuroendocrine carcinomas: A prospective cohort from the Nordic NEC registry

Introduction: Colorectal neuroendocrine carcinoma (CR-NEC) is a rare and aggressive disease. Most cases are metastatic at diagnosis and palliative chemotherapy is the only systemic treatment option.

Conference:

Presenting Author: Morken S

Authors: Morken S, Langer S, Knigge U, Hjortland G, Sundlöv A,

Keywords: neuroendocrine carcinoma, NEC, colorectal, chemotherapy,

#3946 The value of 68Ga-DOTANOC and 18F-FDG PET/CT for predicting the prognosis of patients with metastatic rectal neuroendocrine tumor

Introduction: Rectal neuroendocrine tumor (RNET) is common second only to pancreatic neuroendocrine tumor in Chinese population. Some studies demonstrated that 18F-FDG PET/CT is useful for risk stratification of GEP-NET and is even better than histologic grade to predict the prognosis.

Conference:

Presenting Author: Xu J

Authors: Xu J, Xu X, Liang Y, Huang D, Chen J,

Keywords: rectal neuroendocrine tumor, 68Ga-DOTANOC, 18F-FDG, PET/CT, prognosis,

#3732 Urine 5-HIAA levels and quality-of-life in neuroendocrine neoplasia – Is there an association?

Introduction: Patients with neuroendocrine neoplasia (NEN) experience psychological distress related to secreting tumors. 5-hydroxyindoleacetic acid (5-HIAA) is a metabolite of serotonin, an important secretory product in carcinoid syndrome.

Conference:

Presenting Author:

Authors: Chaudhry R, White B, Chandrakumaran K, Vincent R, Srirajaskanthan R,

Keywords: neuroendocrine neoplasm, biomarker, 5-HIAA, Health-related quality of life (HRQL),

#3294 Clinicopathological characteristics and prognosis of 77 cases with type 3 gastric neuroendocrine tumor

Introduction: Type 3 gastric neuroendocrine tumor (g-NET) is a rare tumor, and few studies have reported its clinicopathological characteristics and prognosis.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Li Y, Chen J, Tan H,

Keywords: type 3 gastric neuroendocrine tumor, clinicopathological characteristics, endoscopic treatment, prognosis,

#3293 Clinicopathological features and risk analysis of lymph node metastasis in type 3 gastric neuroendocrine tumor

Introduction: Type 3 gastric neuroendocrine tumor (NET) are a rare tumor and its high-risk factors of lymph node metastasis remain unclear.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Li Y, Tan H,

Keywords: type 3 gastric neuroendocrine tumor, clinicopathological features, lymph node metastases,